Rheumatoid arthritis and other chronic rheumatic immune mediated diseases affect millions of people worldwide, having a direct impact on quality of life. These disease form part of what are known as Rheumatic and Musculoskeletal Diseases (RMDs). Early diagnosis and appropriate treatments offer hope for people with rheumatic diseases, helping them in their daily lives more than before. We believe that a combination of innovative medicines, better assessment and achievement of sustained clinical goals as well as a deeper understanding and prioritization of what matters most to individuals can support people with RMDs. What matters most to these individuals can cut across relationships, activities, work and aspirations, helping them to live their best possible lives.